$650 Million is the total value of Soleus Capital Management, L.P.'s 65 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 65.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BCAB | Sell | BIOATLA INC | $118,420,000 | -26.7% | 2,794,233 | -12.1% | 18.21% | -37.5% |
EPIX | Buy | ESSA PHARMA INC | $63,943,000 | +6.3% | 2,238,104 | +8.1% | 9.83% | -9.2% |
CCCC | Buy | C4 THERAPEUTICS INC | $32,949,000 | +91.9% | 870,758 | +87.6% | 5.07% | +63.8% |
NPCE | New | NEUROPACE INC | $32,935,000 | – | 1,384,387 | +100.0% | 5.06% | – |
THTX | Buy | THERATECHNOLOGIES INC | $27,269,000 | +1.5% | 7,028,096 | +1.1% | 4.19% | -13.4% |
LNTH | Sell | LANTHEUS HLDGS INC | $25,255,000 | +22.2% | 913,697 | -5.5% | 3.88% | +4.3% |
NVCR | Buy | NOVOCURE LTD | $21,955,000 | +556.0% | 98,975 | +290.8% | 3.38% | +459.9% |
EDAP | Buy | EDAP TMS S Asponsored adr | $18,267,000 | +771.5% | 2,576,401 | +932.4% | 2.81% | +643.1% |
ISEE | Sell | IVERIC BIO INC | $17,721,000 | -15.2% | 2,808,343 | -16.9% | 2.72% | -27.6% |
CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $16,693,000 | – | 103,114 | +100.0% | 2.57% | – |
NEO | Buy | NEOGENOMICS INC | $15,900,000 | +617.5% | 352,007 | +666.0% | 2.44% | +512.8% |
SKIN | New | THE BEAUTY HEALTH COMPANY | $15,697,000 | – | 934,316 | +100.0% | 2.41% | – |
SRDX | Buy | SURMODICS INC | $15,103,000 | +74.6% | 278,404 | +80.5% | 2.32% | +49.0% |
AZN | Sell | ASTRAZENECA PLCsponsored adr | $14,984,000 | +16.6% | 250,146 | -3.2% | 2.30% | -0.5% |
IRMD | Buy | IRADIMED CORP | $14,622,000 | +17.7% | 497,179 | +3.1% | 2.25% | +0.5% |
ITMR | Buy | ITAMAR MED LTDsponsored ads | $12,501,000 | +93.3% | 530,839 | +96.5% | 1.92% | +65.0% |
CVRX | New | CVRX INC | $11,939,000 | – | 426,394 | +100.0% | 1.84% | – |
SIEN | Buy | SIENTRA INC | $11,634,000 | +322.3% | 1,461,563 | +286.8% | 1.79% | +260.7% |
NTRA | Buy | NATERA INC | $11,562,000 | +45.5% | 101,839 | +30.2% | 1.78% | +24.2% |
HOWL | New | WEREWOLF THERAPEUTICS INC | $9,826,000 | – | 563,396 | +100.0% | 1.51% | – |
Buy | GOSSAMER BIO INCnote 5.000% 6/0 | $8,596,000 | +158.3% | 10,700,000 | +185.3% | 1.32% | +120.3% | |
PCVX | Buy | VAXCYTE INC | $8,456,000 | +45.8% | 375,650 | +27.9% | 1.30% | +24.4% |
EOLS | New | EVOLUS INC | $7,337,000 | – | 580,000 | +100.0% | 1.13% | – |
INBX | Sell | INHIBRX INC | $6,682,000 | -17.1% | 242,789 | -39.5% | 1.03% | -29.2% |
EDIT | New | EDITAS MEDICINE INC | $5,415,000 | – | 95,600 | +100.0% | 0.83% | – |
CUTR | Sell | CUTERA INC | $5,049,000 | +40.0% | 102,980 | -14.2% | 0.78% | +19.4% |
YMAB | New | Y-MABS THERAPEUTICS INC | $4,877,000 | – | 144,300 | +100.0% | 0.75% | – |
CMPS | Buy | COMPASS PATHWAYS PLCsponsored ads | $4,873,000 | +209.6% | 127,743 | +198.9% | 0.75% | +163.7% |
KRYS | Sell | KRYSTAL BIOTECH INC | $4,592,000 | -64.3% | 67,529 | -59.5% | 0.71% | -69.5% |
ASMB | ASSEMBLY BIOSCIENCES INC | $4,353,000 | -15.7% | 1,122,000 | 0.0% | 0.67% | -28.1% | |
XENE | Sell | XENON PHARMACEUTICALS INC | $4,351,000 | -65.7% | 233,697 | -67.0% | 0.67% | -70.7% |
INSP | New | INSPIRE MED SYS INC | $4,165,000 | – | 21,550 | +100.0% | 0.64% | – |
MDXG | Sell | MIMEDX GROUP INC | $4,030,000 | -21.7% | 322,160 | -35.6% | 0.62% | -33.2% |
RVMD | Buy | REVOLUTION MEDICINES INC | $3,990,000 | +52.1% | 125,700 | +119.8% | 0.61% | +29.8% |
CELC | New | CELCUITY INC | $3,956,000 | – | 164,824 | +100.0% | 0.61% | – |
LUNG | New | PULMONX CORP | $3,761,000 | – | 85,250 | +100.0% | 0.58% | – |
DYN | Buy | DYNE THERAPEUTICS INC | $3,753,000 | +38.6% | 178,360 | +2.3% | 0.58% | +18.2% |
AXGN | New | AXOGEN INC | $3,417,000 | – | 158,140 | +100.0% | 0.52% | – |
ARYD | ARYA SCIENCES ACQU CORP IVcl a | $3,216,000 | +2.4% | 300,000 | 0.0% | 0.50% | -12.5% | |
BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $3,201,000 | -0.5% | 1,950,000 | 0.0% | 0.49% | -15.0% | ||
BEAM | New | BEAM THERAPEUTICS INC | $2,844,000 | – | 22,100 | +100.0% | 0.44% | – |
GLTO | Sell | GALECTO INC | $2,723,000 | -70.4% | 538,152 | -64.4% | 0.42% | -74.7% |
TKNO | New | ALPHA TEKNOVA INC | $2,718,000 | – | 114,546 | +100.0% | 0.42% | – |
CDNA | New | CAREDX INC | $2,682,000 | – | 29,300 | +100.0% | 0.41% | – |
DXCM | Sell | DEXCOM INC | $2,512,000 | +0.8% | 5,884 | -15.2% | 0.39% | -14.0% |
PODD | New | INSULET CORP | $2,465,000 | – | 8,980 | +100.0% | 0.38% | – |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $2,427,000 | -35.0% | 100,800 | +17.1% | 0.37% | -44.6% |
ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $2,320,000 | -39.3% | 26,568 | -56.6% | 0.36% | -48.2% |
MSON | Sell | MISONIX INC | $2,235,000 | -62.1% | 100,788 | -66.6% | 0.34% | -67.7% |
GH | New | GUARDANT HEALTH INC | $2,173,000 | – | 17,500 | +100.0% | 0.33% | – |
HALO | New | HALOZYME THERAPEUTICS INC | $2,003,000 | – | 44,100 | +100.0% | 0.31% | – |
RFL | Sell | RAFAEL HLDGS INC | $1,876,000 | -45.1% | 36,742 | -57.1% | 0.29% | -53.2% |
EIGR | EIGER BIOPHARMACEUTICALS INC | $1,819,000 | -3.8% | 213,519 | 0.0% | 0.28% | -17.9% | |
GLUE | New | MONTE ROSA THERAPEUTICS INC | $1,703,000 | – | 75,000 | +100.0% | 0.26% | – |
CATABASIS PHARMACEUTICALS IN | $1,635,000 | -27.0% | 775,000 | 0.0% | 0.25% | -37.9% | ||
CMAX | New | CAREMAX INC | $1,534,000 | – | 118,900 | +100.0% | 0.24% | – |
LYRA | Sell | LYRA THERAPEUTICS INC | $1,470,000 | -73.3% | 183,076 | -61.5% | 0.23% | -77.3% |
RNLX | Sell | RENALYTIX PLCads | $1,460,000 | -28.9% | 47,300 | -40.9% | 0.22% | -39.2% |
SBTX | Sell | SILVERBACK THERAPEUTICS INC | $967,000 | -77.2% | 31,306 | -67.8% | 0.15% | -80.5% |
MGTA | Sell | MAGENTA THERAPEUTICS INC | $880,000 | -25.7% | 90,000 | -10.0% | 0.14% | -36.6% |
TCRR | Sell | TCR2 THERAPEUTICS INC | $780,000 | -75.1% | 47,537 | -66.6% | 0.12% | -78.8% |
EWTX | Sell | EDGEWISE THERAPEUTICS INC | $668,000 | -79.4% | 31,300 | -68.7% | 0.10% | -82.4% |
NARI | Sell | INARI MED INC | $574,000 | -75.0% | 6,150 | -71.3% | 0.09% | -78.7% |
KDMN | Sell | KADMON HLDGS INC | $335,000 | -74.4% | 86,442 | -74.3% | 0.05% | -78.0% |
RPTX | Sell | REPARE THERAPEUTICS INC | $228,000 | -94.4% | 7,300 | -94.5% | 0.04% | -95.3% |
CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -42,684 | -100.0% | -0.07% | – |
HIMSWS | Exit | HIMS & HERS HEALTH INC*w exp 01/20/202 | $0 | – | -91,793 | -100.0% | -0.07% | – |
TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -5,577 | -100.0% | -0.10% | – |
MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -3,466 | -100.0% | -0.11% | – |
RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -31,136 | -100.0% | -0.16% | – |
ONCR | Exit | ONCORUS INC | $0 | – | -66,722 | -100.0% | -0.17% | – |
ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -99,992 | -100.0% | -0.18% | – |
KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -28,116 | -100.0% | -0.20% | – |
Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -103,819 | -100.0% | -0.20% | – | |
VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -67,685 | -100.0% | -0.20% | – |
PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.23% | – |
SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -26,101 | -100.0% | -0.24% | – |
MORF | Exit | MORPHIC HLDG INC | $0 | – | -21,500 | -100.0% | -0.24% | – |
DFHT | Exit | DEERFIELD HEALTHCARE TECH AC | $0 | – | -118,900 | -100.0% | -0.26% | – |
OSH | Exit | OAK STR HEALTH INC | $0 | – | -27,612 | -100.0% | -0.27% | – |
OCX | Exit | ONCOCYTE CORP | $0 | – | -297,000 | -100.0% | -0.28% | – |
STAA | Exit | STAAR SURGICAL CO | $0 | – | -16,700 | -100.0% | -0.32% | – |
MRK | Exit | MERCK & CO. INC | $0 | – | -30,106 | -100.0% | -0.42% | – |
RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -109,130 | -100.0% | -0.43% | – |
ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -313,064 | -100.0% | -0.60% | – |
KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -109,000 | -100.0% | -0.61% | – |
Exit | DARIOHEALTH CORP | $0 | – | -178,814 | -100.0% | -0.62% | – | |
PHG | Exit | KONINKLIJKE PHILIPS N Vny reg sh new | $0 | – | -61,050 | -100.0% | -0.63% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -25,318 | -100.0% | -0.70% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -182,347 | -100.0% | -0.74% | – |
FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -522,500 | -100.0% | -0.84% | – |
VSPR | Exit | VESPER HEALTHCARE ACQSTN COR | $0 | – | -920,716 | -100.0% | -1.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
IRADIMED CORP | 16 | Q3 2023 | 5.8% |
XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
SURMODICS INC | 14 | Q3 2023 | 4.7% |
NATERA INC | 13 | Q3 2023 | 3.9% |
DEXCOM INC | 13 | Q2 2023 | 4.2% |
NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.